Molecular monitoring of minimal residual disease after non-myeloablative allografting for multiple myeloma

被引：0
|
作者：
Bruno, B
Ladetto, M
Mordini, N
Astolfi, M
Rotta, M
Cimolin, L
Compagno, M
Veneziano, L
Aitoro, G
Gallamini, A
Storb, R
Boccadoro, M
机构：
来源：
BONE MARROW TRANSPLANTATION | 2003年 / 31卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S123 / S124
页数：2
相关论文
共 50 条
  • [31] Stem cell allografting using a non-myeloablative regimen.
    Tan, P
    Tee, GY
    BLOOD, 1996, 88 (10) : 449 - 449
  • [32] Long-Term Follow up of a Comparison of Non-Myeloablative Allografting with Autografting for Newly Diagnosed Myeloma
    Bruno, Benedetto
    Storer, Barry
    Patriarca, Francesca
    Rotta, Marcello
    Sorasio, Roberto
    Allione, Bernardino
    Carnevale-Schianca, Fabrizio
    Giaccone, Luisa
    Festuccia, Moreno
    Brunello, Lucia
    Omede, Paola
    Ferrando, Federica
    Bringlien, Sara
    Aglietta, Massimo
    Levis, Alessandro
    Mordini, Nicola
    Gallamini, Andrea
    Palumbo, Antonio
    Fanin, Renato
    Storb, Rainer
    Gooley, Ted
    Boccadoro, Mario
    BLOOD, 2010, 116 (21) : 233 - 233
  • [33] Non-myeloablative allograft to induce graft versus myeloma effect after cytoreductive autotransplant for multiple myeloma.
    Kroeger, N
    Renges, H
    Krueger, W
    Stute, N
    Zabelina, T
    Schrum, J
    Wittkowsky, G
    Kuse, R
    Hegewisch-Becker, S
    Zander, AR
    BLOOD, 2000, 96 (11) : 782A - 782A
  • [34] MINIMAL RESIDUAL DISEASE AFTER BMT FOR MULTIPLE-MYELOMA
    BIRD, JM
    SAMSON, D
    RUSSELL, NH
    BLOOD, 1993, 82 (10) : A199 - A199
  • [35] Minimal Residual Disease in Multiple Myeloma
    Munshi, Nikhil C.
    Anderson, Kenneth C.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (20) : 2523 - 2526
  • [36] Minimal residual disease for multiple myeloma
    Avet-Loiseau, Herve
    Corre, Jill
    HEMATOLOGIE, 2019, 25 : 36 - 39
  • [37] Minimal residual disease in multiple myeloma
    Moukalled, Nour
    Malard, Florent
    Bazarbachi, Ali
    Mohty, Mohamad
    PRESSE MEDICALE, 2025, 54 (01):
  • [38] NON-MYELOABLATIVE ALLOGRAFTS IN MULTIPLE MYELOMA: TIME FOR A RE-LOOK?
    Gibbs, S. D. J.
    Shipton, M. James
    Bodagh, N.
    Rodriguez, O. Rafael
    Dignan, F.
    Waller, M.
    Woodward, J.
    Tholouli, E.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S345 - S345
  • [39] Tumour markers for monitoring minimal residual disease in multiple myeloma.
    Rothwell, DG
    Kalakonda, N
    Norton, JD
    Hawkins, RE
    Chopra, R
    BLOOD, 2000, 96 (11) : 151A - 151A
  • [40] Minimal Residual Disease Monitoring During Maintenance In Multiple Myeloma Patients
    Rocci, Alberto
    Gambella, Manuela
    Omede, Paola
    Drandi, Daniela
    Gay, Francesca
    Patriarca, Francesca
    Cavallo, Federica
    Petrucci, Maria Teresa
    Tommaso, Caravita
    Benevolo, Giulia
    Pescosta, Norbert
    Oliva, Stefania
    Offidani, Massimo
    Montefusco, Vittorio
    Liberati, Anna Marina
    Falcone, Antonietta Pia
    Ballanati, Stelvio
    Spadano, Tonino
    Guglielmelli, Tommasina
    Musto, Pellegrino
    Zarnbello, Renato
    Di Raimondo, Francesco
    Ladetto, Marco
    Boccadoro, Mario
    Palumbo, Antonio
    BLOOD, 2013, 122 (21)
12345